קימטרק ישראל - עברית - Ministry of Health

קימטרק

medison pharma ltd - tebentafusp - תרכיז להכנת תמיסה לאינפוזיה - tebentafusp 0.2 mg/ml - tebentafusp

קרבגלו ישראל - עברית - Ministry of Health

קרבגלו

medison pharma ltd - carglumic acid - טבליות ניתנות לפיזור - carglumic acid 200 mg - carglumic acid - carglumic acid - carbaglu is indicated in treatment of :- hyperammonaemia due to n - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.

נגלזיים ישראל - עברית - Ministry of Health

נגלזיים

medison pharma ltd - galsulfase - תרכיז להכנת תמיסה לאינפוזיה - galsulfase 1 mg/ml - galsulfase - galsulfase - naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mpsvi (n-acetylglactosamine 4 sulfatase deficiency maroteaux-lamy syndrome).

קובן ישראל - עברית - Ministry of Health

קובן

medison pharma ltd - sapropterin dihydrochloride - טבליות מסיסות - sapropterin dihydrochloride 100 mg - sapropterin - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adult and paediatric patients of 4 years of age and over with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adult and paediatric patients with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

נודקסטה ישראל - עברית - Ministry of Health

נודקסטה

medison pharma ltd - dextromethorphan hydrobromide; quinidine sulfate - קפסולות - quinidine sulfate 10 mg; dextromethorphan hydrobromide 20 mg - quinidine - quinidine - for the treatment of pseudobulbar affect (pba) in als and ms patients only.

קוראלאן 7.5 מג ישראל - עברית - Ministry of Health

קוראלאן 7.5 מג

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

קוראלאן 5 מג ישראל - עברית - Ministry of Health

קוראלאן 5 מג

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

בזפיברט 400 ישראל - עברית - Ministry of Health

בזפיברט 400

medison pharma ltd - bezafibrate - טבליות עם שחרור מושהה - bezafibrate 400 mg - bezafibrate - bezafibrate - hyperlipidemia of types iia, iib, iii, iv, v in patients where diet alone is insufficient.

נוטרופין איי.קיו 10 מ"ג/2 מ"ל ישראל - עברית - Ministry of Health

נוטרופין איי.קיו 10 מ"ג/2 מ"ל

medison pharma ltd - somatropin 5 mg / 1 ml - solution for injection - somatropin - 1. long-term treatment of children with growth failure due to inadequateendogenous growth hormone secretion.2. long-term treatment of growth failure associated with turner syndrome. 3. treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation. 4. replacement of endogenous growth hormone in adults with growth hormone deficiency or either childhood or adult-onset etiology. growth hormone deficiency of either childhood or adult-onset etiology. growth hormone deficiency should be confirmed appropriately prior to treatment.

סומטולין ש.מ. 30 מג ישראל - עברית - Ministry of Health

סומטולין ש.מ. 30 מג

medison pharma ltd - lanreotide acetate - אבקה וממס להכנת תרחיף להזרקה - lanreotide acetate 0.03 g/vial - lanreotide - lanreotide - treatment of acromegaly (when the treatment of growth hormone is not normalized after surgery and/or radiotherapy). treatment of the clinical symptoms of carcinoid tumors (after a test injection). treatment of primary thyrotropic adenomas responsible for hypethyroidism as a preparation for / or as a complement to surgery and/or radiotherapy or where these therapies are unsuitable.